Planegg, Germany

Sabine Jung-Imhof

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Engmab Ag. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabine Jung-Imhof. Retrieved from https://idiyas.com/inventor/sabine-jung-imhof

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 16.9

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sabine Jung-Imhof: Innovator in Bispecific Antibodies

Introduction

Sabine Jung-Imhof is a prominent inventor based in Planegg, Germany. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. With a total of 2 patents, her work is paving the way for innovative treatments in cancer therapy.

Latest Patents

Her latest patents include bispecific antibodies against CD3EPSILON and ROR1. This invention relates to the manufacture and use of these antibodies, which target ROR1 and CD3. Another notable patent involves bispecific antibodies against CD3 and BCMA. This invention describes a bispecific bi- or trivalent antibody that specifically binds to the extracellular domain of human B cell maturation antigen (BCMA) and human CD3. The patent details specific amino acid substitutions in the constant domains of the antibody, enhancing its therapeutic potential.

Career Highlights

Throughout her career, Sabine has worked with notable companies such as Engmab AG and Bristol-Myers Squibb Company. Her experience in these organizations has contributed to her expertise in antibody development and biopharmaceutical research.

Collaborations

Sabine has collaborated with esteemed colleagues, including Minh Diem Vu and Klaus Strein. These partnerships have further enriched her research and innovation in the field.

Conclusion

Sabine Jung-Imhof is a trailblazer in the development of bispecific antibodies, with her patents reflecting her commitment to advancing medical science. Her work continues to inspire future innovations in biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…